
    
      The study will be a single center, open label, prospective, non-comparative, randomized trial
      and assess the safety and performance of the Rapid Ring device. In order to assess pain
      reduction, a comparative study will be performed and each subject will serve as his/her own
      control.

      Clinical assessment for all 100% patients will occur at baseline. All participants will be
      men and women above the age of 18. The trial will be conducted at a Medical Center.
    
  